Tag:
phenoxodiol
Latest Headlines
Latest Headlines
Marshall Edwards shares crash on PhIII cancer failure
Shares of Marshall Edwards ( NASDAQ: MSHL ) plummeted yesterday evening after the developer reported that its therapy for ovarian cancer--phenoxodiol--had failed to hit key endpoints in a late-stage
Novogen cuts staff, focuses on oncology
Australia's Novogen announced today that it will suspend its cardiovascular and anti-inflammatory programs to focus its resources on advancing its oncology business. "With the current economic
